Protection of nucleosides
AssigneeIsis Pharmaceuticals, Inc.
InventorsQuanlai Song, Bruce S. Ross
Life of this patent
Estimating the term…
Loading patent…
AssigneeIsis Pharmaceuticals, Inc.
InventorsQuanlai Song, Bruce S. Ross
Estimating the term…
A process of manufacturing protected nucleosides comprises reacting a nucleoside with a protecting reagent in the presence of a regioselective activator to produce a regioselectively protected nucleoside. In some embodiments of the inventive method, an optionally substituted trityl or optionally substituted pixyl group is selectively added to the 5′-O-position of a nucleoside in the presence of lutidine as activator or activator/solvent. The inventive method results in improved selectivity of the 5′-O-position over the 3′-O-position, thereby improving overall product yield and purity, and permitting simplified purification protocols, in some cases obviating the need for chromatography to produce a purified protected nucleoside suitable for automated synthesis of oligonucleotides, such as primers, probes and antisense molecules.
A process comprising contacting a nucleoside with a hindered aryl amine activator and a protecting reagent to produce a regioselectively 5′ mono-protected nucleoside.
Dependencies are inferred from the claim text.